PMA approvals

VENTANA PTEN (SP218) RxDx Assay

Ventana Medical Systems, Inc. (Roche Tissue Diagnostics) · Immunohistochemistry Assay, Antibody · Pathology

P250031Original PMAApproved
Open FDA's page for this record
PMA number
P250031
Applicant
Ventana Medical Systems, Inc. (Roche Tissue Diagnostics)
Street 1
1910 E. Innovation Park Dr.
City
Tucson
State
AZ
Zip
85755
Generic name
Immunohistochemistry Assay, Antibody
Trade name
VENTANA PTEN (SP218) RxDx Assay
Product code
SHF
Advisory committee
PA
Advisory committee description
Pathology
Expedited review flag
N
Date received
2025-08-18
Decision date
2026-06-12
Docket number
26M-6735
Fed reg notice date
2026-06-12
Decision code
APPR
Ao statement

VENTANA PTEN (SP218) RxDx Assay is a qualitative immunohistochemical (IHC) assay using rabbit monoclonal anti-PTEN, clone SP218, intended for laboratory use in the assessment of phosphatase and tensin homolog (PTEN) protein in formalin-fixed paraffin-embedded (FFPE) prostatic adenocarcinoma tissue specimens by light microscopy. The assay is for use with OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument. The assay is indicated as a companion diagnostic to aid in identifying patients who may be eligible for treatment with TRUQAP (capivasertib) in combination with abiraterone acetate in accordance with the approved therapeutic product labeling. The clinical cutoff for PTEN Loss status is >=90% of viable malignant cells with no specific cytoplasmic staining.Test results should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls.This product is intended for in vitro diagnostic (IVD) use.

Harmonized identifiers (openFDA)
Registration number
2028492
FEI number
1000125183
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.